Invention Grant
US08772013B2 Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
有权
通过细菌衍生的完整微细胞靶向体外和体内药物递送到哺乳动物细胞的方法
- Patent Title: Methods for targeted in vitro and in vivo drug delivery to mammalian cells via bacterially derived intact minicells
- Patent Title (中): 通过细菌衍生的完整微细胞靶向体外和体内药物递送到哺乳动物细胞的方法
-
Application No.: US10588028Application Date: 2005-01-27
-
Publication No.: US08772013B2Publication Date: 2014-07-08
- Inventor: Himanshu Brahmbhatt , Jennifer MacDiarmid
- Applicant: Himanshu Brahmbhatt , Jennifer MacDiarmid
- Applicant Address: AU Sydney
- Assignee: Engeneic Molecular Delivery Pty Ltd
- Current Assignee: Engeneic Molecular Delivery Pty Ltd
- Current Assignee Address: AU Sydney
- Agency: Foley & Lardner LLP
- International Application: PCT/IB2005/000204 WO 20050127
- International Announcement: WO2005/079854 WO 20050901
- Main IPC: C12N1/20
- IPC: C12N1/20 ; A61K47/00 ; A61K47/46 ; A61K31/337

Abstract:
A composition comprising intact minicells that contain a drug molecule is useful for targeted drug delivery. One targeted drug delivery method employs bispecific ligands, comprising a first arm that carries specificity for a bacterially derived minicell surface structure and a second arm that carries specificity for a mammalian cell surface receptor, to target drug-loaded minicells to specific mammalian cells and to cause endocytosis of the minicells by the mammalian cells. Another drug delivery method exploits the natural ability of phagocytic mammalian cells to engulf minicells without the use of bispecific ligands.
Public/Granted literature
Information query
IPC分类: